{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:53:27Z","timestamp":1775235207522,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/fpc.0b013e32835366f6","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T09:20:23Z","timestamp":1334654423000},"page":"525-537","source":"Crossref","is-referenced-by-count":9,"title":["Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1"],"prefix":"10.1097","volume":"22","author":[{"given":"Wen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia M.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Kulmacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210213","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"key":"R2-6-20210213","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review.","volume":"297","author":"Campbell","year":"2007","journal-title":"JAMA"},{"key":"R4-6-20210213","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R5-6-20210213","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"R6-6-20210213","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1073\/pnas.72.12.4863","article-title":"Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs.","volume":"72","author":"Rome","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-6-20210213","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1021\/bi00289a010","article-title":"Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase.","volume":"22","author":"Roth","year":"1983","journal-title":"Biochemistry"},{"key":"R9-6-20210213","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","article-title":"The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.","volume":"56","author":"Roth","year":"1975","journal-title":"J Clin Invest"},{"key":"R10-6-20210213","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase.","volume":"2","author":"Loll","year":"1995","journal-title":"Nat Struct Biol"},{"key":"R11-6-20210213","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/j.1538-7836.2005.01555.x","article-title":"Cyclooxygenase-1 haplotype modulates platelet response to aspirin.","volume":"3","author":"Maree","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R14-6-20210213","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0167-4838(94)90148-1","article-title":"Purification, characterization and selective inhibition of human prostaglandin GH synthase 1 and 2 expressed in the baculovirus system.","volume":"1209","author":"Barnett","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"R15-6-20210213","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.fpc.0000236340.87540.e3","article-title":"Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).","volume":"17","author":"Lee","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R16-6-20210213","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition.","volume":"50","author":"Blobaum","year":"2007","journal-title":"J Med Chem"},{"key":"R17-6-20210213","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.","volume":"96","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-6-20210213","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/abbi.1995.1100","article-title":"Prostaglandin H synthase-1: evaluation of C-terminus function.","volume":"316","author":"Ren","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"R19-6-20210213","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/humu.9080","article-title":"Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations.","volume":"20","author":"Ulrich","year":"2002","journal-title":"Hum Mutat"},{"key":"R20-6-20210213","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jinorgbio.2009.04.002","article-title":"Peroxide-induced radical formation at TYR385 and TYR504 in human PGHS-1.","volume":"103","author":"Rogge","year":"2009","journal-title":"J Inorg Biochem"},{"key":"R21-6-20210213","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/tpj.2010.49","article-title":"Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.","volume":"11","author":"Liu","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"R22-6-20210213","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0076-6879(83)91014-5","article-title":"Determination of total protein.","volume":"91","author":"Peterson","year":"1983","journal-title":"Methods Enzymol"},{"key":"R23-6-20210213","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4.","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"R24-6-20210213","first-page":"36","article-title":"Image processing with ImageJ.","volume":"11","author":"Abramoff","year":"2004","journal-title":"Biophotonics Int"},{"key":"R26-6-20210213","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1096\/fj.05-5273com","article-title":"Divergent cyclooxygenase responses to fatty acid structure and peroxide level in fish and mammalian prostaglandin H synthases.","volume":"20","author":"Liu","year":"2006","journal-title":"FASEB J"},{"key":"R27-6-20210213","doi-asserted-by":"crossref","first-page":"12572","DOI":"10.1016\/S0021-9258(17)38909-3","article-title":"Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.","volume":"260","author":"Kulmacz","year":"1985","journal-title":"J Biol Chem"},{"key":"R28-6-20210213","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"R29-6-20210213","first-page":"240","article-title":"Salts of acetylsalicylic acid.","volume":"406","author":"Gerngross","year":"1914","journal-title":"Eur J Org Chem"},{"key":"R30-6-20210213","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1023\/A:1018953920081","article-title":"Kinetics of aspirin hydrolysis and stabilization in the presence of 2-hydroxypropyl-beta-cyclodextrin.","volume":"10","author":"Choudhury","year":"1993","journal-title":"Pharm Res"},{"key":"R31-6-20210213","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0090-6980(89)90133-0","article-title":"Concerted loss of cyclooxygenase and peroxidase activities from prostaglandin H synthase upon proteolytic attack.","volume":"38","author":"Kulmacz","year":"1989","journal-title":"Prostaglandins"},{"key":"R32-6-20210213","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0076-6879(82)86219-8","article-title":"Extraction and thin-layer chromatography of arachidonic acid metabolites.","volume":"86","author":"Salmon","year":"1982","journal-title":"Methods Enzymol"},{"key":"R33-6-20210213","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jps.2600720914","article-title":"Stability of aspirin in different media.","volume":"72","author":"Bakar","year":"1983","journal-title":"J Pharm Sci"},{"key":"R34-6-20210213","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0163-7827(03)00023-7","article-title":"Comparison of the properties of prostaglandin H synthase-1 and -2.","volume":"42","author":"Kulmacz","year":"2003","journal-title":"Prog Lipid Res"},{"key":"R35-6-20210213","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prostaglandins.2007.12.001","article-title":"Phospholipid actions on PGHS-1 and -2 cyclooxygenase kinetics.","volume":"85","author":"Doyen","year":"2008","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R36-6-20210213","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1021\/bi00010a023","article-title":"The catalytic outcomes of the constitutive and the mitogen inducible isoforms of prostaglandin H2 synthase are markedly affected by glutathione and glutathione peroxidase(s).","volume":"34","author":"Capdevila","year":"1995","journal-title":"Biochemistry"},{"key":"R37-6-20210213","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1067\/mcp.2003.1","article-title":"Genetic variation in cyclooxygenase 1: effects on response to aspirin.","volume":"73","author":"Halushka","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R38-6-20210213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1183\/09031936.05.00140104","article-title":"Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy.","volume":"26","author":"Shi","year":"2005","journal-title":"Eur Respir J"},{"key":"R39-6-20210213","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.abb.2009.08.019","article-title":"Prostaglandin H synthase: resolved and unresolved mechanistic issues.","volume":"493","author":"Tsai","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"R40-6-20210213","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1074\/jbc.M009377200","article-title":"Prostaglandin endoperoxide H synthase-1: the functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid.","volume":"276","author":"Thuresson","year":"2001","journal-title":"J Biol Chem"},{"key":"R41-6-20210213","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/abbi.1999.1659","article-title":"Purification and characterization of the human recombinant histidine-tagged prostaglandin endoperoxide H synthases-1 and -2.","volume":"375","author":"Smith","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"R42-6-20210213","doi-asserted-by":"crossref","first-page":"27357","DOI":"10.1016\/S0021-9258(18)46993-1","article-title":"Investigation of the role of cysteines in catalysis by prostaglandin endoperoxide synthase.","volume":"269","author":"Kennedy","year":"1994","journal-title":"J Biol Chem"},{"key":"R43-6-20210213","doi-asserted-by":"crossref","first-page":"34820","DOI":"10.1074\/jbc.M111.267161","article-title":"Intracellular erythrocyte platelet-activating factor acetylhydrolase I inactivates aspirin in blood.","volume":"286","author":"Zhou","year":"2011","journal-title":"J Biol Chem"},{"key":"R44-6-20210213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.2042-7158.1975.tb09472.x","article-title":"A simultaneous determination of acetylsalicylic acid, salicylic acid and salicylamide in plasma by gas liquid chromatography.","volume":"27","author":"Rance","year":"1975","journal-title":"J Pharm Pharmacol"},{"key":"R45-6-20210213","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/215413a0","article-title":"Kinetics of acetylsalicylic acid disposition in man.","volume":"215","author":"Rowland","year":"1967","journal-title":"Nature"},{"key":"R46-6-20210213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1749-6632.1971.tb46905.x","article-title":"Salicylate metabolism in man.","volume":"179","author":"Davison","year":"1971","journal-title":"Ann N Y Acad Sci"},{"key":"R47-6-20210213","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"key":"R48-6-20210213","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2174\/092986710793205408","article-title":"Selective COX-1 inhibition: a therapeutic target to be reconsidered.","volume":"17","author":"Perrone","year":"2010","journal-title":"Curr Med Chem"},{"key":"R49-6-20210213","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/1940-6207.CAPR-11-0391","article-title":"Aspirin in the chemoprevention of colorectal neoplasia: an overview.","volume":"5","author":"Chan","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"R50-6-20210213","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/138920009790711814","article-title":"Pharmacogenomics in aspirin intolerance.","volume":"10","author":"Agundez","year":"2009","journal-title":"Curr Drug Metab"},{"key":"R51-6-20210213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.clpt.6100221","article-title":"Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.","volume":"83","author":"Lee","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R52-6-20210213","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cercor\/bhq236","article-title":"Neurovascular coupling in the human visual cortex is modulated by cyclooxygenase-1 (COX-1) gene variant.","volume":"21","author":"Hahn","year":"2011","journal-title":"Cereb Cortex"},{"key":"R53-6-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1388-1981(99)00105-5","article-title":"PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.","volume":"1440","author":"Rosenstock","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"R54-6-20210213","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-2999(00)00931-6","article-title":"Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs.","volume":"412","author":"Rosenstock","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R55-6-20210213","doi-asserted-by":"crossref","first-page":"14583","DOI":"10.1073\/pnas.251543298","article-title":"A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin.","volume":"98","author":"Ouellet","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R56-6-20210213","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.0909765106","article-title":"Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.","volume":"107","author":"Rimon","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-201207000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T21:51:23Z","timestamp":1618350683000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201207000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32835366f6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717955331.793460488","asserted-by":"object"}]},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}